Susquehanna International Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
50,300
+16,800
+50% +$400K ﹤0.01% 7323
2025
Q4
$782K Sell
33,500
-229,600
-87% -$5.11M ﹤0.01% 7744
2025
Q3
$5.18M Buy
263,100
+51,200
+24% +$1.05M ﹤0.01% 4032
2025
Q2
$4.6M Buy
211,900
+200,800
+1,809% +$4.74M ﹤0.01% 4122
2025
Q1
$269K Buy
+11,100
New +$250K ﹤0.01% 10303
2024
Q4
Sell
-35,700
Closed -$710K 12324
2024
Q3
$710K Buy
+35,700
New +$662K ﹤0.01% 7615
2023
Q3
Sell
-26,900
Closed -$362K 12118
2023
Q2
$362K Buy
26,900
+11,900
+79% +$171K ﹤0.01% 9061
2023
Q1
$249K Buy
15,000
+2,500
+20% +$41.2K ﹤0.01% 10135
2022
Q4
$233K Sell
12,500
-7,400
-37% -$114K ﹤0.01% 9748
2022
Q3
$255K Buy
+19,900
New +$236K ﹤0.01% 10221
2021
Q4
Sell
-26,200
Closed -$139K 13186
2021
Q3
$139K Sell
26,200
-147,800
-85% -$808K ﹤0.01% 11845
2021
Q2
$1M Buy
174,000
+163,600
+1,573% +$844K ﹤0.01% 7750
2021
Q1
$48K Sell
10,400
-15,100
-59% -$60K ﹤0.01% 12041
2020
Q4
$85K Sell
25,500
-51,500
-67% -$173K ﹤0.01% 10575
2020
Q3
$229K Buy
+77,000
New +$301K ﹤0.01% 9238
2020
Q2
Sell
-12,000
Closed -$46K 10202
2020
Q1
$46K Sell
12,000
-1,000
-8% -$4.11K ﹤0.01% 9711
2019
Q4
$49K Sell
13,000
-61,300
-83% -$287K ﹤0.01% 9348
2019
Q3
$395K Sell
74,300
-189,200
-72% -$1.01M ﹤0.01% 7766
2019
Q2
$1.01M Buy
263,500
+158,400
+151% +$684K ﹤0.01% 5629
2019
Q1
$536K Buy
105,100
+90,600
+625% +$266K ﹤0.01% 6136
2018
Q4
$28K Sell
14,500
-39,500
-73% -$113K ﹤0.01% 8630
2018
Q3
$204K Buy
54,000
+28,800
+114% +$90.2K ﹤0.01% 8182
2018
Q2
$79K Sell
25,200
-2,400
-9% -$7.28K ﹤0.01% 9136
2018
Q1
$66K Hold
27,600
﹤0.01% 8864
2017
Q4
$108K Buy
27,600
+11,500
+71% +$38K ﹤0.01% 8659
2017
Q3
$41K Buy
16,100
+2,900
+22% +$7.96K ﹤0.01% 8573
2017
Q2
$36K Buy
+13,200
New +$27.6K ﹤0.01% 8952
2015
Q3
Sell
-14,700
Closed -$61K 9666
2015
Q2
$61K Buy
14,700
+200
+1% +$797 ﹤0.01% 9827
2015
Q1
$63K Buy
+14,500
New +$52.3K ﹤0.01% 9102
2014
Q4
Sell
-27,300
Closed -$91K 9652
2014
Q3
$91K Buy
+27,300
New +$71.3K ﹤0.01% 9102

Other funds holding CPRX